Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
RESEARCH TOOLSreports
Holding UPC?
Track your performance easily
UPC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.75 - $4.32
Previous Close$3.3
Volume266.13K
Average Volume (3M)61.78K
Market Cap
$12.03M
Enterprise Value-$990.08K
Total Cash (Recent Filing)$18.50M
Total Debt (Recent Filing)$5.48M
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Jul 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.70
Shares Outstanding3,645,974
10 Day Avg. Volume33,905
30 Day Avg. Volume61,785
Standard Deviation0.35
R-Squared0.06
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.24
Price to Sales (P/S)0.30
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-0.10
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Universe Pharmaceuticals News
PremiumCompany Announcements
Universe Pharmaceuticals Raises $25 Million in Offering
Ownership Overview
0.00%
Insiders
0.04% Mutual Funds
0.00% Other Institutional Investors
99.96% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
UPC FAQ
What was Universe Pharmaceuticals’s price range in the past 12 months?
Universe Pharmaceuticals lowest stock price was $0.75 and its highest was $4.32 in the past 12 months.
What is Universe Pharmaceuticals’s market cap?
Currently, no data Available
When is Universe Pharmaceuticals’s upcoming earnings report date?
Universe Pharmaceuticals’s upcoming earnings report date is Jul 29, 2024 which is 26 days ago.
How were Universe Pharmaceuticals’s earnings last quarter?
Universe Pharmaceuticals released its earnings results on Jan 30, 2024. The company reported -$1.503 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.503.
Is Universe Pharmaceuticals overvalued?
According to Wall Street analysts Universe Pharmaceuticals’s price is currently Overvalued.
Does Universe Pharmaceuticals pay dividends?
Universe Pharmaceuticals does not currently pay dividends.
What is Universe Pharmaceuticals’s EPS estimate?
Universe Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Universe Pharmaceuticals have?
Universe Pharmaceuticals has 3,645,974 shares outstanding.
What happened to Universe Pharmaceuticals’s price movement after its last earnings report?
Universe Pharmaceuticals reported an EPS of -$1.503 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.451%.
Which hedge fund is a major shareholder of Universe Pharmaceuticals?
Currently, no hedge funds are holding shares in UPC
---
Universe Pharmaceuticals Stock Smart Score
Company Description
Universe Pharmaceuticals
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
---
Technical Analysis
---